IRIS Accounts Production v25.4.0.155 05559798 Board of Directors Board of Directors Board of Directors 1.11.24 31.10.25 31.10.25 true false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh055597982024-10-31055597982025-10-31055597982024-11-012025-10-31055597982023-10-31055597982023-11-012024-10-31055597982024-10-3105559798ns15:EnglandWales2024-11-012025-10-3105559798ns14:PoundSterling2024-11-012025-10-3105559798ns10:Director12024-11-012025-10-3105559798ns10:Director22024-11-012025-10-3105559798ns10:Director32024-11-012025-10-3105559798ns10:PrivateLimitedCompanyLtd2024-11-012025-10-3105559798ns10:SmallEntities2024-11-012025-10-3105559798ns10:AuditExempt-NoAccountantsReport2024-11-012025-10-3105559798ns10:SmallCompaniesRegimeForDirectorsReport2024-11-012025-10-3105559798ns10:SmallCompaniesRegimeForAccounts2024-11-012025-10-3105559798ns10:FullAccounts2024-11-012025-10-310555979812024-11-012025-10-3105559798ns5:CurrentFinancialInstruments2025-10-3105559798ns5:CurrentFinancialInstruments2024-10-3105559798ns5:ShareCapital2025-10-3105559798ns5:ShareCapital2024-10-3105559798ns5:CapitalRedemptionReserve2025-10-3105559798ns5:CapitalRedemptionReserve2024-10-3105559798ns5:RetainedEarningsAccumulatedLosses2025-10-3105559798ns5:RetainedEarningsAccumulatedLosses2024-10-3105559798ns10:RegisteredOffice2024-11-012025-10-3105559798ns5:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-3105559798ns5:PatentsTrademarksLicencesConcessionsSimilar2024-11-012025-10-3105559798ns5:LeaseholdImprovements2024-11-012025-10-3105559798ns5:PlantMachinery2024-11-012025-10-3105559798ns5:FurnitureFittings2024-11-012025-10-3105559798ns5:ComputerEquipment2024-11-012025-10-3105559798ns5:PatentsTrademarksLicencesConcessionsSimilar2024-10-3105559798ns5:PatentsTrademarksLicencesConcessionsSimilar2025-10-3105559798ns5:PatentsTrademarksLicencesConcessionsSimilar2024-10-3105559798ns5:LeaseholdImprovements2024-10-3105559798ns5:PlantMachinery2024-10-3105559798ns5:FurnitureFittings2024-10-3105559798ns5:ComputerEquipment2024-10-3105559798ns5:LeaseholdImprovements2025-10-3105559798ns5:PlantMachinery2025-10-3105559798ns5:FurnitureFittings2025-10-3105559798ns5:ComputerEquipment2025-10-3105559798ns5:LeaseholdImprovements2024-10-3105559798ns5:PlantMachinery2024-10-3105559798ns5:FurnitureFittings2024-10-3105559798ns5:ComputerEquipment2024-10-3105559798ns5:CostValuation2024-10-3105559798ns5:WithinOneYearns5:CurrentFinancialInstruments2025-10-3105559798ns5:WithinOneYearns5:CurrentFinancialInstruments2024-10-31
REGISTERED NUMBER: 05559798 (England and Wales)














Unaudited Financial Statements

for the Year Ended 31 October 2025

for

Symbiosys Business Solutions Limited

Symbiosys Business Solutions Limited (Registered number: 05559798)






Contents of the Financial Statements
for the Year Ended 31 October 2025




Page

Balance Sheet 1

Notes to the Financial Statements 3


Symbiosys Business Solutions Limited (Registered number: 05559798)

Balance Sheet
31 October 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 6,667 -
Tangible assets 5 1,292 2,175
Investments 6 1 1
7,960 2,176

CURRENT ASSETS
Debtors 7 80,841 118,687
Cash at bank 196,131 254,933
276,972 373,620
CREDITORS
Amounts falling due within one year 8 141,658 207,364
NET CURRENT ASSETS 135,314 166,256
TOTAL ASSETS LESS CURRENT LIABILITIES 143,274 168,432

PROVISIONS FOR LIABILITIES 323 544
NET ASSETS 142,951 167,888

CAPITAL AND RESERVES
Called up share capital 300 300
Capital reserve 12,472 12,472
Retained earnings 130,179 155,116
SHAREHOLDERS' FUNDS 142,951 167,888

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Symbiosys Business Solutions Limited (Registered number: 05559798)

Balance Sheet - continued
31 October 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved on by the Board of Directors and authorised for issue on 3 April 2026 and were signed on its behalf by:




Mr M A Minshull - Director Mr A W Elson - Director




Mrs L F Elson - Director


Symbiosys Business Solutions Limited (Registered number: 05559798)

Notes to the Financial Statements
for the Year Ended 31 October 2025

1. STATUTORY INFORMATION

Symbiosys Business Solutions Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 05559798

Registered office: First Floor Park View House
Worrall Street
Congleton
Cheshire
CW12 1DT

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Preparation of consolidated financial statements
The financial statements contain information about Symbiosys Business Solutions Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

Turnover
Turnover represents net invoiced sales of goods/services, excluding value added tax.

Revenue is recognised as the company becomes entitled to consideration for the services supplied. Therefore, turnover also includes the element of work completed but not yet invoiced.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of three years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Website - 33% on cost
Plant and machinery - 50% on reducing balance
Fixtures and fittings - 25% on reducing balance
Computer equipment - 50% on reducing balance

Website has now been fully depreciated.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Symbiosys Business Solutions Limited (Registered number: 05559798)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2025

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2024 - 6 ) .

4. INTANGIBLE FIXED ASSETS
Patents
and
licences
£   
COST
At 1 November 2024 21,975
Additions 10,000
At 31 October 2025 31,975
AMORTISATION
At 1 November 2024 21,975
Amortisation for year 3,333
At 31 October 2025 25,308
NET BOOK VALUE
At 31 October 2025 6,667
At 31 October 2024 -

Symbiosys Business Solutions Limited (Registered number: 05559798)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2025

5. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
Website machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1 November 2024
and 31 October 2025 6,760 3,348 5,963 70,583 86,654
DEPRECIATION
At 1 November 2024 6,760 2,599 5,147 69,973 84,479
Charge for year - 374 204 305 883
At 31 October 2025 6,760 2,973 5,351 70,278 85,362
NET BOOK VALUE
At 31 October 2025 - 375 612 305 1,292
At 31 October 2024 - 749 816 610 2,175

6. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 November 2024
and 31 October 2025 1
NET BOOK VALUE
At 31 October 2025 1
At 31 October 2024 1

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 33,786 47,826
Other debtors 47,055 70,861
80,841 118,687

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors 3,002 4,307
Taxation and social security 30,917 23,531
Other creditors 107,739 179,526
141,658 207,364